NCT00557700View on ClinicalTrials.gov

Study to Investigate the Effect of Inhaled Tiotropium Bromide on Neurokinin-A Induced Bronchoconstriction in Patients With Mild-to-moderate Asthma

PHASE2CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions

Asthma

Interventions

DRUG

Administration of inhaled tiotropium bromide

Administration of inhaled tiotropium bromide

DRUG

Administration of placebo

Administration of placebo

Trial Locations (2)

4000

CHU Sart Tilman ULG, Liège

9000

University Hospital Ghent, Ghent

Sponsors

Collaborators (1)

Boehringer Ingelheim

All Listed Sponsors

collaborator

Boehringer Ingelheim

INDUSTRY

lead

University Hospital, Ghent

OTHER